High-Throughput Chinmedomics Strategy Discovers the Quality Markers and Mechanisms of Wutou Decoction Therapeutic for Rheumatoid Arthritis

• Published in: Frontiers in pharmacology Vol. 13; p. 854087
• Main Authors: Li, Taiping, Wu, Fangfang, Zhang, Aihua, Dong, Hui, Ullah, Ihsan, Lin, Hao, Miao, Jianhua, Sun, Hui, Han, Ying, He, Yanmei, Wang, Xijun
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 12.04.2022
• Subjects: biomarker; chinmedomics; mass spectrometry; metabolomics; pathway; Pharmacology; quality markers; effective subustance; chinmedomics; metabolomics; mass spectrometry; pathway; biomarker; quality markers
• ISSN: 1663-9812; 1663-9812
• DOI: 10.3389/fphar.2022.854087

Wutou decoction (WTD) is a traditional Chinese medicine prescription for the treatment of rheumatoid arthritis (RA), and this study systematically analyzed the metabolic mechanism and key pharmacodynamic components of WTD in RA rats by combining untargeted metabolomics and serum pharmacochemistry of traditional Chinese medicine to enrich the evidence of WTD quality markers (Q-markers) studies. WTD prevented synovial edema in RA rats and reduced tumor necrosis factor-alpha and interleukin 6 levels in rat serum, according to the results of an enzyme-linked immunosorbent examination and histopathological inspection. In model rats, pattern recognition and multivariate statistical analysis revealed 24 aberrant metabolites that disrupted linoleic acid metabolism, arachidonic acid metabolism, arginine and proline metabolism, etc . However, continued dosing of WTD for 28 days reversed 13 abnormal metabolites, which may be an important therapeutic mechanism from a metabolomic perspective. Importantly, 12 prototypical components and 16 metabolites from WTD were characterized in RA rat serum. The results of Pearson correlation analysis showed that aconitine, L-ephedrine, L-methylephedrine, quercetin, albiflorin, paeoniflorigenone, astragaline A, astragaloside II, glycyrrhetic acid, glycyrrhizic acid, licurazide, and isoliquiritigenin are the key pharmacological components that regulate the metabolism of RA rats, and they are identified as Q-markers. In sum, utilizing metabolomics and serum pharmacochemistry of traditional Chinese medicine, the metabolic mechanisms and Q-markers of WTD therapy in RA rats were revealed, providing a theoretical basis for the quality control investigation of WTD.